Literature DB >> 29279458

Whole-genome sequencing revealed armadillo repeat containing 5 (ARMC5) mutation in a Chinese family with ACTH-independent macronodular adrenal hyperplasia.

Qian Zhang1,2, Liang Cui3, Jiang-Ping Gao4, Wen-Hua Yan1, Nan Jin1, Kang Chen1, Li Zang1, Jin Du1, Xian-Ling Wang1, Qing-Hua Guo1, Guo-Qing Yang1, Li-Juan Yang1, Jian-Ming Ba1, Wei-Jun Gu1, Zhao-Hui Lv1, Jing-Tao Dou1, Yi-Ming Mu1, Ju-Ming Lu1.   

Abstract

Primary macronodular adrenal hyperplasia (PMAH), also known in the past as bilateral macronodular adrenalhyperplasia or adrenocorticotropin (ACTH)-independent macronodular adrenal hyperplasia, is a rare type of Cushing's syndrome (CS) and is associated with bilateralenlargement of the adrenal glands. It accounts for <1% of all endogenous cases of CS. In order toidentify the pathogenic mutations in the causative gene of (AIMAH pedigrees, Whole-genome sequencing of three patients in family I was used to retrieve candidate causative genes. Meanwhile, the causative gene was identified by Sanger sequencing from the two pedigrees. Sequencing of ARMC5 exons of three patients was carried out to identify somatic mutations. Moreover, haploid clone of one tumor DNA sample was conducted. ARMC5 was the causative gene of two pedigrees confirmed by whole-genome sequencing (WGA) and Sanger sequencing. The variant sites of the two families were c.C943T (p.R315W) and c.C1960T (p.R654X), respectively. Autosomal dominant inheritance of AIMAH was confirmed by genotypes of one family member. Several somatic mutations were discovered in tumor DNA samples. In addition, haploid clone of tumor DNA was confirmed by germline mutation and somaticmutation, which suggested the pathogenic mechanism of "two-hit-model." ARMC5 was the causative gene of AIMAH pedigrees. This AIMAH in this study presented autosomal dominant inheritance, fitting to Mendelian inheritance law. However, the pathogenic mode of this disease showed as compound heterozygote.

Entities:  

Keywords:  Armadillo repeat containing 5 (ARMC5); Gene; Pedigree; Whole-genome sequencing

Mesh:

Substances:

Year:  2017        PMID: 29279458     DOI: 10.1507/endocrj.EJ17-0317

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  4 in total

1.  ARMC5 Alterations in Primary Macronodular Adrenal Hyperplasia (PMAH) and the Clinical State of Variant Carriers.

Authors:  Chika Kyo; Takeshi Usui; Rieko Kosugi; Mizuki Torii; Takako Yonemoto; Tatsuo Ogawa; Masato Kotani; Naohisa Tamura; Yutaro Yamamoto; Takuyuki Katabami; Isao Kurihara; Kohei Saito; Naotetsu Kanamoto; Hidenori Fukuoka; Norio Wada; Hiroyuki Murabe; Tatsuhide Inoue
Journal:  J Endocr Soc       Date:  2019-07-23

2.  MicroRNA expression signature and target prediction in familial and sporadic primary macronodular adrenal hyperplasia (PMAH).

Authors:  Xiao-Gang Tan; Jie Zhu; Liang Cui
Journal:  BMC Endocr Disord       Date:  2022-01-05       Impact factor: 2.763

3.  A novel pathogenic variant of ARMC5 in a patient with primary bilateral macronodular adrenal hyperplasia: a case report.

Authors:  Wei Wang; Feng Wei
Journal:  BMC Endocr Disord       Date:  2022-08-22       Impact factor: 3.263

4.  Sum of High-Risk Gene Mutation (SHGM): A Novel Attempt to Assist Differential Diagnosis for Adrenocortical Carcinoma with Benign Adenoma, Based on Detection of Mutations of Nine Target Genes.

Authors:  Guo-Yang Zheng; Xue-Bin Zhang; Han-Zhong Li; Yu-Shi Zhang; Jian-Hua Deng; Xing-Cheng Wu
Journal:  Biochem Genet       Date:  2021-02-09       Impact factor: 1.890

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.